Ghose K, Coppen A
Psychopharmacology (Berl). 1977 Aug 31;54(1):57-60. doi: 10.1007/BF00426542.
The tyramine-dose/pressor response test was carried out on a series of patients suffering from primary depressive illness before and during treatment with amitriptyline. The severity of their depression was assessed during the study of the Hamilton Rating Scale (HRS). The decreased tyramine sensitivity induced by the drug, which is related to the inhibition of NA reuptake, correlated significantly with the plasma concentration of nortriptyline. However, contrary to the expectation of the noradrenaline hypothesis of depression, the decreased tyramine sensitivity, i.e., the degree of NA-reuptake blockade, did not show any correlation with clinical improvement following 6 weeks' treatment with amitriptyline.
对一系列患有原发性抑郁症的患者在服用阿米替林治疗前和治疗期间进行了酪胺剂量/升压反应试验。在汉密尔顿评定量表(HRS)研究期间评估了他们的抑郁严重程度。药物引起的酪胺敏感性降低与去甲肾上腺素(NA)再摄取的抑制有关,与去甲替林的血浆浓度显著相关。然而,与抑郁症的去甲肾上腺素假说预期相反,酪胺敏感性降低,即NA再摄取阻断程度,与阿米替林治疗6周后的临床改善没有任何相关性。